GEMINA LABORATORIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 CAD | 0.00% |
|
-6.67% | -22.22% |
| 05-31 | Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2024 | CI |
| 04-02 | Gemina Laboratories Sign First Strategic License Agreement | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEMINA LABORATORIES LTD. | Diagnostic & Testing Substances | 0.00% | -6.67% | -22.22% | -28.81% | - | 22.53M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- GLAB Stock
- Charts Gemina Laboratories Ltd.
- Comparison Chart
